Quantum BioPharma hits midpoint in mass general imaging study for multiple sclerosis
Quantum BioPharma (NASDAQ:QNTM) has reached the halfway enrollment mark in its collaborative clinical study with Massachusetts General Hospital (MGH), yielding encouraging preliminary imaging data.



_1401896_640x360_2500436035532-640x360.webp&w=3840&q=75)




_1401863_640x360_2500431939516-640x360.webp&w=3840&q=75)


